Shares of Viveve Medical, Inc. (NASDAQ:VIVE) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $12.80.

VIVE has been the topic of a number of analyst reports. ValuEngine raised shares of Viveve Medical from a “strong sell” rating to a “sell” rating in a report on Friday, June 2nd. Raymond James Financial, Inc. initiated coverage on shares of Viveve Medical in a report on Thursday, May 25th. They set an “outperform” rating and a $10.00 price objective on the stock. Cowen and Company initiated coverage on shares of Viveve Medical in a report on Wednesday, May 3rd. They set an “outperform” rating and a $11.00 price objective on the stock. Maxim Group reaffirmed a “buy” rating and set a $11.00 price objective on shares of Viveve Medical in a report on Friday. Finally, B. Riley reaffirmed a “buy” rating and set a $10.00 price objective on shares of Viveve Medical in a report on Wednesday, May 17th.

COPYRIGHT VIOLATION WARNING: “Viveve Medical, Inc. (VIVE) Given Average Recommendation of “Buy” by Brokerages” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/viveve-medical-inc-vive-given-average-recommendation-of-buy-by-brokerages/1473468.html.

Viveve Medical (NASDAQ:VIVE) traded down 0.28% during mid-day trading on Friday, reaching $7.03. 194,671 shares of the company’s stock traded hands. Viveve Medical has a 12 month low of $3.75 and a 12 month high of $11.16. The company has a 50 day moving average price of $7.06 and a 200-day moving average price of $6.44. The stock’s market cap is $136.06 million.

Viveve Medical (NASDAQ:VIVE) last posted its quarterly earnings data on Thursday, August 10th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.33) by $0.21. The firm had revenue of $3.08 million for the quarter, compared to analysts’ expectations of $3.24 million. Viveve Medical had a negative return on equity of 232.94% and a negative net margin of 255.11%. Viveve Medical’s revenue was up 97.4% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.66) earnings per share. On average, analysts anticipate that Viveve Medical will post ($1.81) EPS for the current year.

Several large investors have recently added to or reduced their stakes in the company. Rhumbline Advisers acquired a new stake in Viveve Medical during the second quarter worth approximately $110,000. JPMorgan Chase & Co. acquired a new stake in Viveve Medical during the second quarter worth approximately $151,000. Schwab Charles Investment Management Inc. acquired a new stake in Viveve Medical during the second quarter worth approximately $189,000. Teachers Advisors LLC acquired a new stake in Viveve Medical during the second quarter worth approximately $196,000. Finally, TIAA CREF Investment Management LLC acquired a new stake in Viveve Medical during the second quarter worth approximately $296,000. Institutional investors own 61.75% of the company’s stock.

Viveve Medical Company Profile

Viveve Medical, Inc designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories.

Analyst Recommendations for Viveve Medical (NASDAQ:VIVE)

Receive News & Ratings for Viveve Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.